Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones12-14

DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ inched 0.19% higher to $21.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.12% to 19,926.72 and the Dow Jones Industrial Average falling 0.20% to 43,828.06.

The stock's rise snapped a two-day losing streak.

Catalyst Pharmaceuticals Inc. closed $2.89 below its 52-week high ($24.27), which the company reached on November 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.26% to $146.62, Pfizer Inc. $(PFE)$ rose 0.83% to $25.58, and Abbott Laboratories $(ABT)$ fell 0.42% to $113.38.

Data source: Dow Jones Market Data, FactSet. Data compiled December 13, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 13, 2024 17:22 ET (22:22 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491058189?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-14 06:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491058189","market":"sg","top_or_hot":-1,"title":"Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Catalyst Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/CPRX\">$(CPRX)$</a> inched 0.19% higher to $21.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.12% to 19,926.72 and the Dow Jones Industrial Average  falling 0.20% to 43,828.06. \n</p>\n<p>\n     The stock's rise snapped a two-day losing streak. \n</p>\n<p>\n     Catalyst Pharmaceuticals Inc. closed $2.89 below its 52-week high ($24.27), which the company reached on November 8th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.26% to $146.62, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> rose 0.83% to $25.58, and Abbott Laboratories <a href=\"https://laohu8.com/S/ABT\">$(ABT)$</a> fell 0.42% to $113.38. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 13, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 13, 2024 17:22 ET (22:22 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCatalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-14 06:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CPRX","symbol_name":"Catalyst Pharmaceutical Partners","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2491058189","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491058189","pubTimestamp":1734128520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Catalyst Pharmaceuticals Inc.  inched 0.19% higher to $21.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.12% to 19,926.72 and the Dow Jones Industrial Average  falling 0.20% to 43,828.06.The stock's rise snapped a two-day losing streak.Catalyst Pharmaceuticals Inc. closed $2.89 below its 52-week high , which the company reached on November 8th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.26% to $146.62, Pfizer Inc.  rose 0.83% to $25.58, and Abbott Laboratories  fell 0.42% to $113.38.Data source: Dow Jones Market Data, FactSet. Data compiled December 13, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jour","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CPRX":"Catalyst Pharmaceutical Partners"},"translate_title":"尽管每日上涨，但与竞争对手相比，Catalyst Pharmaceuticals Inc.的股票周五表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPRX":0.6},"content_text":"DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ inched 0.19% higher to $21.38 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.12% to 19,926.72 and the Dow Jones Industrial Average  falling 0.20% to 43,828.06. \n\n\n     The stock's rise snapped a two-day losing streak. \n\n\n     Catalyst Pharmaceuticals Inc. closed $2.89 below its 52-week high ($24.27), which the company reached on November 8th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.26% to $146.62, Pfizer Inc. $(PFE)$ rose 0.83% to $25.58, and Abbott Laboratories $(ABT)$ fell 0.42% to $113.38. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 13, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 13, 2024 17:22 ET (22:22 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491058189"}